Interestingly, the therapeutic impact of adoptively transferred NK cells was dependent on endogenous CD8 + T cells with NK cell adoptive therapy facilitating the development of a tumor-specific CD8+ T-cell response in the host. This evidence concerns the gene CD8A and neoplasm.